International Journal of Molecular Sciences | |
Clinical Evaluation of Extracellular ADMA Concentrations in Human Blood and Adipose Tissue | |
Marcus May2  Sandor Batkai1  Alexander A. Zörner2  Dimitrios Tsikas2  Jens Jordan2  | |
[1] Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany; E-Mail:;Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany; E-Mails: | |
关键词: asymmetric dimethylarginine; nitric oxide; nitric oxide synthase; dimethylarginine dimethylaminohydrolase; adipose tissue; diabetes; obesity; | |
DOI : 10.3390/ijms15011189 | |
来源: mdpi | |
【 摘 要 】
Circulating asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, has been proposed as a biomarker for clinical outcome. Dimethylarginine dimethylaminohydrolase (DDAH) is the main enzyme responsible for ADMA metabolism and elimination. Adipose tissue ADMA concentrations and DDAH activity and their role in diabetes and obesity have not yet been investigated. In this study, we evaluated clinical microdialysis in combination with a sensitive analytical method (GC-MS/MS) to measure ADMA concentrations in extracellular fluid. Adipose tissue ADMA concentrations were assessed before and during an oral glucose tolerance test in lean healthy subjects and subjects with diabetes (
【 授权许可】
CC BY
© 2014 by the authors; licensee MDPI, Basel, Switzerland
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190029753ZK.pdf | 246KB | download |